Clinical Trial Detail

NCT ID NCT03393611
Title CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

anti-thymocyte globulin + Fludarabine + Melphalan

CPX-351

Age Groups: adult senior

No variant requirements are available.